| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diet, Mediterranean | 33 | 2023 | 700 | 7.980 |
Why?
|
| Weight Loss | 44 | 2024 | 2625 | 4.950 |
Why?
|
| Obesity, Abdominal | 16 | 2022 | 361 | 4.680 |
Why?
|
| Araceae | 6 | 2021 | 15 | 4.350 |
Why?
|
| Diet, Fat-Restricted | 18 | 2022 | 320 | 2.790 |
Why?
|
| Wine | 5 | 2019 | 165 | 2.370 |
Why?
|
| Dyslipidemias | 8 | 2022 | 849 | 2.210 |
Why?
|
| Obesity | 45 | 2024 | 12746 | 2.150 |
Why?
|
| Abdominal Fat | 4 | 2017 | 223 | 1.980 |
Why?
|
| Diet, Reducing | 15 | 2022 | 462 | 1.870 |
Why?
|
| Diet, Carbohydrate-Restricted | 13 | 2022 | 262 | 1.850 |
Why?
|
| Intra-Abdominal Fat | 11 | 2022 | 591 | 1.610 |
Why?
|
| Israel | 29 | 2021 | 796 | 1.540 |
Why?
|
| Tea | 6 | 2023 | 275 | 1.470 |
Why?
|
| Life Style | 21 | 2024 | 3835 | 1.440 |
Why?
|
| Diabetes Mellitus, Type 2 | 24 | 2023 | 11726 | 1.320 |
Why?
|
| Adiposity | 9 | 2022 | 1806 | 1.270 |
Why?
|
| Plant Proteins | 2 | 2020 | 364 | 1.190 |
Why?
|
| Plant Extracts | 2 | 2020 | 471 | 1.110 |
Why?
|
| Triglycerides | 13 | 2021 | 2453 | 1.070 |
Why?
|
| Adipose Tissue | 10 | 2023 | 3280 | 1.020 |
Why?
|
| Juglans | 2 | 2022 | 43 | 1.010 |
Why?
|
| Exercise | 18 | 2023 | 5615 | 0.980 |
Why?
|
| Dietary Carbohydrates | 7 | 2017 | 905 | 0.940 |
Why?
|
| Nutritional Physiological Phenomena | 3 | 2020 | 370 | 0.940 |
Why?
|
| Basal Metabolism | 3 | 2016 | 168 | 0.930 |
Why?
|
| Lipids | 9 | 2017 | 3307 | 0.900 |
Why?
|
| Energy Intake | 12 | 2019 | 2148 | 0.850 |
Why?
|
| Body Fat Distribution | 2 | 2021 | 244 | 0.820 |
Why?
|
| Postprandial Period | 3 | 2019 | 292 | 0.790 |
Why?
|
| Blood Glucose | 12 | 2022 | 6254 | 0.760 |
Why?
|
| Coronary Disease | 11 | 2011 | 6077 | 0.750 |
Why?
|
| Weight Gain | 5 | 2023 | 2293 | 0.750 |
Why?
|
| Waist Circumference | 9 | 2020 | 917 | 0.720 |
Why?
|
| Ghrelin | 1 | 2022 | 266 | 0.710 |
Why?
|
| Feeding Behavior | 13 | 2011 | 3188 | 0.710 |
Why?
|
| Fatty Liver | 3 | 2022 | 727 | 0.700 |
Why?
|
| Middle Aged | 82 | 2023 | 213390 | 0.680 |
Why?
|
| Diet | 17 | 2023 | 7937 | 0.660 |
Why?
|
| Alcohol Dehydrogenase | 2 | 2015 | 119 | 0.640 |
Why?
|
| Magnetic Resonance Imaging | 14 | 2024 | 35425 | 0.620 |
Why?
|
| Dietary Supplements | 3 | 2020 | 3296 | 0.610 |
Why?
|
| Vitamin B 12 | 1 | 2020 | 527 | 0.600 |
Why?
|
| Body Mass Index | 30 | 2024 | 12721 | 0.570 |
Why?
|
| Liver | 4 | 2021 | 7475 | 0.530 |
Why?
|
| Adult | 76 | 2023 | 214052 | 0.530 |
Why?
|
| Gastroplasty | 3 | 2003 | 142 | 0.530 |
Why?
|
| Alcohol Drinking | 5 | 2021 | 3966 | 0.530 |
Why?
|
| Pancreatic Diseases | 1 | 2018 | 350 | 0.530 |
Why?
|
| Male | 90 | 2023 | 350115 | 0.520 |
Why?
|
| Dietary Fats | 7 | 2017 | 2016 | 0.520 |
Why?
|
| Nutrition Policy | 2 | 2020 | 488 | 0.520 |
Why?
|
| Fasting | 8 | 2023 | 1592 | 0.510 |
Why?
|
| Anemia, Iron-Deficiency | 2 | 2019 | 365 | 0.510 |
Why?
|
| Humans | 129 | 2024 | 744366 | 0.480 |
Why?
|
| Thermogenesis | 2 | 2016 | 434 | 0.480 |
Why?
|
| Biological Availability | 3 | 2019 | 397 | 0.480 |
Why?
|
| Female | 88 | 2023 | 380193 | 0.480 |
Why?
|
| Subcutaneous Fat | 5 | 2021 | 391 | 0.470 |
Why?
|
| Subcutaneous Fat, Abdominal | 2 | 2012 | 93 | 0.460 |
Why?
|
| Risk Reduction Behavior | 2 | 2017 | 1125 | 0.460 |
Why?
|
| Metabolomics | 2 | 2024 | 1485 | 0.460 |
Why?
|
| DNA Methylation | 4 | 2023 | 4285 | 0.460 |
Why?
|
| Occupational Health | 2 | 2018 | 808 | 0.460 |
Why?
|
| Ethanol | 2 | 2021 | 1342 | 0.450 |
Why?
|
| Cholesterol, HDL | 11 | 2021 | 1813 | 0.450 |
Why?
|
| Pericardium | 1 | 2017 | 667 | 0.440 |
Why?
|
| Adipose Tissue, White | 1 | 2015 | 351 | 0.420 |
Why?
|
| Health Maintenance Organizations | 2 | 2012 | 642 | 0.410 |
Why?
|
| Health Promotion | 4 | 2020 | 2205 | 0.410 |
Why?
|
| Overweight | 6 | 2024 | 2371 | 0.400 |
Why?
|
| Cyclobutanes | 1 | 2011 | 59 | 0.390 |
Why?
|
| Insulin Resistance | 9 | 2022 | 3864 | 0.390 |
Why?
|
| Lipoprotein(a) | 2 | 2005 | 435 | 0.390 |
Why?
|
| Pancreas | 1 | 2018 | 1687 | 0.380 |
Why?
|
| Aging | 4 | 2023 | 8664 | 0.380 |
Why?
|
| Iron | 1 | 2019 | 1774 | 0.380 |
Why?
|
| Kidney | 2 | 2017 | 7184 | 0.350 |
Why?
|
| Adipokines | 1 | 2011 | 320 | 0.340 |
Why?
|
| Blood Pressure | 4 | 2018 | 8551 | 0.340 |
Why?
|
| Adipose Tissue, Brown | 1 | 2015 | 756 | 0.340 |
Why?
|
| Lactones | 1 | 2011 | 329 | 0.330 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2011 | 336 | 0.330 |
Why?
|
| Carotid Artery Diseases | 2 | 2018 | 879 | 0.330 |
Why?
|
| Diabetic Angiopathies | 4 | 2007 | 818 | 0.320 |
Why?
|
| Anti-Obesity Agents | 1 | 2011 | 217 | 0.310 |
Why?
|
| Diet Surveys | 6 | 2010 | 1173 | 0.310 |
Why?
|
| Energy Metabolism | 3 | 2017 | 2897 | 0.310 |
Why?
|
| Cell Adhesion Molecules | 2 | 2020 | 1602 | 0.300 |
Why?
|
| Cardiovascular Diseases | 9 | 2023 | 15160 | 0.300 |
Why?
|
| Nutritive Value | 3 | 2021 | 339 | 0.300 |
Why?
|
| Feces | 2 | 2023 | 1401 | 0.280 |
Why?
|
| Leptin | 2 | 2011 | 1600 | 0.270 |
Why?
|
| Food | 3 | 2014 | 772 | 0.270 |
Why?
|
| C-Reactive Protein | 7 | 2023 | 3778 | 0.270 |
Why?
|
| Atherosclerosis | 4 | 2019 | 3444 | 0.260 |
Why?
|
| Calorimetry, Indirect | 2 | 2016 | 183 | 0.260 |
Why?
|
| Epigenomics | 2 | 2021 | 903 | 0.260 |
Why?
|
| Patient Compliance | 5 | 2015 | 2684 | 0.260 |
Why?
|
| Cholesterol | 4 | 2011 | 2919 | 0.250 |
Why?
|
| Homocysteine | 2 | 2004 | 647 | 0.250 |
Why?
|
| Omentum | 5 | 2016 | 170 | 0.250 |
Why?
|
| Follow-Up Studies | 20 | 2021 | 39052 | 0.240 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 2 | 2017 | 22 | 0.240 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2006 | 707 | 0.240 |
Why?
|
| Food Labeling | 2 | 2020 | 178 | 0.240 |
Why?
|
| Arabs | 4 | 2010 | 178 | 0.240 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 2 | 2005 | 357 | 0.230 |
Why?
|
| Hypertension | 3 | 2015 | 8479 | 0.230 |
Why?
|
| Food Analysis | 1 | 2003 | 104 | 0.220 |
Why?
|
| MicroRNAs | 3 | 2022 | 3751 | 0.200 |
Why?
|
| Chin | 1 | 2021 | 38 | 0.200 |
Why?
|
| Alanine Transaminase | 3 | 2016 | 592 | 0.200 |
Why?
|
| Medication Adherence | 2 | 2018 | 2063 | 0.200 |
Why?
|
| Aspartate Aminotransferases | 2 | 2016 | 418 | 0.190 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2020 | 72 | 0.190 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 4925 | 0.190 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2020 | 32 | 0.190 |
Why?
|
| Treatment Outcome | 14 | 2022 | 63107 | 0.190 |
Why?
|
| Thyrotropin | 1 | 2023 | 849 | 0.180 |
Why?
|
| Adiponectin | 4 | 2016 | 1101 | 0.170 |
Why?
|
| Aged | 29 | 2021 | 163288 | 0.170 |
Why?
|
| Plants, Edible | 1 | 2019 | 30 | 0.170 |
Why?
|
| Hypercholesterolemia | 2 | 2003 | 1151 | 0.170 |
Why?
|
| Yogurt | 1 | 2019 | 72 | 0.170 |
Why?
|
| Creatinine | 2 | 2016 | 1919 | 0.170 |
Why?
|
| Satiation | 1 | 2019 | 80 | 0.170 |
Why?
|
| Amino Acids, Essential | 1 | 2018 | 24 | 0.170 |
Why?
|
| Aquatic Organisms | 1 | 2019 | 48 | 0.170 |
Why?
|
| Epigenesis, Genetic | 2 | 2023 | 3646 | 0.170 |
Why?
|
| Physician-Patient Relations | 1 | 2012 | 3229 | 0.170 |
Why?
|
| Sex Factors | 5 | 2022 | 10400 | 0.160 |
Why?
|
| Body Composition | 4 | 2021 | 2402 | 0.160 |
Why?
|
| Propionates | 1 | 2019 | 169 | 0.160 |
Why?
|
| Nutrition Surveys | 3 | 2009 | 1660 | 0.160 |
Why?
|
| Iron, Dietary | 1 | 2019 | 141 | 0.160 |
Why?
|
| Jews | 5 | 2008 | 385 | 0.150 |
Why?
|
| Genotype | 4 | 2018 | 12952 | 0.150 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2018 | 147 | 0.150 |
Why?
|
| Adipocytes | 2 | 2016 | 1185 | 0.150 |
Why?
|
| Atrophy | 1 | 2022 | 1584 | 0.150 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2019 | 300 | 0.150 |
Why?
|
| Neck | 1 | 2021 | 698 | 0.150 |
Why?
|
| Cholesterol, LDL | 5 | 2015 | 2355 | 0.150 |
Why?
|
| Dietary Proteins | 5 | 2022 | 963 | 0.150 |
Why?
|
| Regression Analysis | 7 | 2014 | 6459 | 0.150 |
Why?
|
| Glucagon | 1 | 2019 | 533 | 0.140 |
Why?
|
| Glucose Intolerance | 1 | 2021 | 577 | 0.140 |
Why?
|
| CpG Islands | 1 | 2021 | 1170 | 0.140 |
Why?
|
| Risk Factors | 15 | 2021 | 72296 | 0.140 |
Why?
|
| Calcium-Binding Proteins | 1 | 2021 | 1081 | 0.140 |
Why?
|
| Fruit | 4 | 2014 | 1142 | 0.140 |
Why?
|
| Health Personnel | 2 | 2009 | 3219 | 0.140 |
Why?
|
| Primary Health Care | 1 | 2012 | 4557 | 0.130 |
Why?
|
| Endocrine Glands | 1 | 2016 | 103 | 0.130 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2011 | 1677 | 0.130 |
Why?
|
| Hydrocortisone | 1 | 2023 | 1826 | 0.130 |
Why?
|
| Dietetics | 2 | 2009 | 35 | 0.130 |
Why?
|
| Postmenopause | 1 | 2004 | 2460 | 0.130 |
Why?
|
| Autophagy | 2 | 2016 | 1297 | 0.130 |
Why?
|
| Caloric Restriction | 1 | 2018 | 302 | 0.130 |
Why?
|
| Cohort Studies | 12 | 2019 | 40559 | 0.130 |
Why?
|
| Nuts | 1 | 2017 | 257 | 0.130 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2011 | 3922 | 0.130 |
Why?
|
| Apolipoprotein A-I | 3 | 2011 | 281 | 0.130 |
Why?
|
| Thigh | 1 | 2016 | 247 | 0.130 |
Why?
|
| Attitude of Health Personnel | 1 | 2009 | 3841 | 0.130 |
Why?
|
| Education | 1 | 2018 | 543 | 0.130 |
Why?
|
| Uric Acid | 1 | 2020 | 766 | 0.120 |
Why?
|
| Zinc | 2 | 2018 | 684 | 0.120 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2014 | 110 | 0.120 |
Why?
|
| Mass Spectrometry | 1 | 2021 | 2204 | 0.120 |
Why?
|
| Time Factors | 7 | 2017 | 40075 | 0.120 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2015 | 236 | 0.120 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 2029 | 0.120 |
Why?
|
| Diet Therapy | 1 | 2014 | 154 | 0.120 |
Why?
|
| Endocrine System Diseases | 1 | 2016 | 248 | 0.110 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 2 | 2004 | 66 | 0.110 |
Why?
|
| Lipoproteins, HDL | 1 | 2018 | 638 | 0.110 |
Why?
|
| Metabolism | 1 | 2014 | 196 | 0.110 |
Why?
|
| Inflammation | 5 | 2011 | 10637 | 0.110 |
Why?
|
| Testosterone | 1 | 2023 | 2419 | 0.110 |
Why?
|
| Foam Cells | 1 | 2013 | 71 | 0.110 |
Why?
|
| Patient Satisfaction | 2 | 2003 | 3395 | 0.110 |
Why?
|
| Phenotype | 3 | 2017 | 16367 | 0.110 |
Why?
|
| Apolipoprotein B-100 | 3 | 2011 | 148 | 0.110 |
Why?
|
| Dairy Products | 3 | 2014 | 498 | 0.110 |
Why?
|
| Bone Marrow | 1 | 2023 | 2948 | 0.110 |
Why?
|
| Macrophages | 3 | 2016 | 5660 | 0.110 |
Why?
|
| Multivariate Analysis | 7 | 2011 | 12244 | 0.100 |
Why?
|
| Brain | 4 | 2024 | 26388 | 0.100 |
Why?
|
| Vegetables | 2 | 2011 | 1182 | 0.100 |
Why?
|
| Risk | 5 | 2016 | 9688 | 0.100 |
Why?
|
| Copper | 1 | 2014 | 366 | 0.100 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 18034 | 0.100 |
Why?
|
| Endothelium, Vascular | 1 | 2004 | 4459 | 0.100 |
Why?
|
| Retinol-Binding Proteins | 1 | 2011 | 65 | 0.100 |
Why?
|
| Selenium | 1 | 2014 | 405 | 0.100 |
Why?
|
| Health Status | 2 | 2021 | 4034 | 0.100 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2015 | 546 | 0.100 |
Why?
|
| Magnesium | 1 | 2014 | 813 | 0.100 |
Why?
|
| Intention to Treat Analysis | 1 | 2012 | 426 | 0.100 |
Why?
|
| Organ Size | 1 | 2016 | 2251 | 0.100 |
Why?
|
| Kidney Function Tests | 1 | 2013 | 683 | 0.100 |
Why?
|
| Carbohydrates | 1 | 2013 | 394 | 0.090 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 2213 | 0.090 |
Why?
|
| Nutrition Disorders | 2 | 2003 | 211 | 0.090 |
Why?
|
| Folic Acid | 3 | 2010 | 1300 | 0.090 |
Why?
|
| Self-Assessment | 1 | 2012 | 390 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2916 | 0.090 |
Why?
|
| Serpins | 1 | 2011 | 247 | 0.090 |
Why?
|
| Bread | 1 | 2009 | 23 | 0.090 |
Why?
|
| Tunica Media | 1 | 2010 | 113 | 0.090 |
Why?
|
| Dietary Fats, Unsaturated | 2 | 2008 | 226 | 0.090 |
Why?
|
| Amino Acids | 1 | 2016 | 1737 | 0.090 |
Why?
|
| Health Surveys | 2 | 2018 | 4036 | 0.090 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2024 | 954 | 0.090 |
Why?
|
| Diabetes Mellitus | 3 | 2018 | 5749 | 0.090 |
Why?
|
| Albuminuria | 1 | 2013 | 681 | 0.080 |
Why?
|
| Body Weight | 3 | 2015 | 4671 | 0.080 |
Why?
|
| Workplace | 2 | 2012 | 836 | 0.080 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2009 | 148 | 0.080 |
Why?
|
| Adolescent | 3 | 2020 | 85779 | 0.080 |
Why?
|
| Organizational Culture | 1 | 2012 | 510 | 0.080 |
Why?
|
| Meat | 1 | 2011 | 592 | 0.080 |
Why?
|
| Homeostasis | 1 | 2019 | 3339 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2016 | 9955 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 8300 | 0.080 |
Why?
|
| Databases, Factual | 1 | 2003 | 7730 | 0.080 |
Why?
|
| Quality of Life | 3 | 2015 | 12802 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2017 | 4222 | 0.080 |
Why?
|
| Tunica Intima | 1 | 2010 | 464 | 0.080 |
Why?
|
| Calcium, Dietary | 1 | 2010 | 526 | 0.080 |
Why?
|
| Predictive Value of Tests | 3 | 2017 | 15078 | 0.070 |
Why?
|
| Cross-Sectional Studies | 4 | 2017 | 25039 | 0.070 |
Why?
|
| Ketones | 1 | 2008 | 188 | 0.070 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 452 | 0.070 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2011 | 430 | 0.070 |
Why?
|
| Diet Records | 2 | 2010 | 425 | 0.070 |
Why?
|
| Spouses | 1 | 2009 | 286 | 0.070 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2022 | 251 | 0.070 |
Why?
|
| Monocytes | 1 | 2016 | 2596 | 0.070 |
Why?
|
| United States Department of Agriculture | 2 | 2003 | 48 | 0.070 |
Why?
|
| Incidence | 4 | 2011 | 20952 | 0.070 |
Why?
|
| Apolipoproteins B | 2 | 2006 | 374 | 0.070 |
Why?
|
| Animals | 8 | 2020 | 168768 | 0.070 |
Why?
|
| Self Concept | 1 | 2012 | 1025 | 0.070 |
Why?
|
| Comprehension | 1 | 2011 | 610 | 0.070 |
Why?
|
| Lipid Metabolism | 2 | 2019 | 1889 | 0.070 |
Why?
|
| Insulin | 3 | 2022 | 6582 | 0.070 |
Why?
|
| Young Adult | 5 | 2020 | 56429 | 0.070 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 697 | 0.070 |
Why?
|
| Smoking | 4 | 2009 | 8987 | 0.070 |
Why?
|
| Carotid Arteries | 1 | 2010 | 950 | 0.060 |
Why?
|
| Glomerular Filtration Rate | 1 | 2013 | 2166 | 0.060 |
Why?
|
| Testicular Hormones | 1 | 2005 | 188 | 0.060 |
Why?
|
| Hypertriglyceridemia | 1 | 2008 | 293 | 0.060 |
Why?
|
| Survival | 1 | 2005 | 163 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2011 | 6366 | 0.060 |
Why?
|
| Fibrinogen | 2 | 2005 | 894 | 0.060 |
Why?
|
| Linear Models | 2 | 2011 | 5953 | 0.060 |
Why?
|
| Self Disclosure | 1 | 2005 | 251 | 0.060 |
Why?
|
| Health Care Surveys | 1 | 2011 | 2453 | 0.060 |
Why?
|
| Thiamine | 1 | 2004 | 152 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2011 | 9849 | 0.060 |
Why?
|
| beta Carotene | 1 | 2005 | 527 | 0.060 |
Why?
|
| Chorionic Gonadotropin | 1 | 2005 | 476 | 0.060 |
Why?
|
| Lipoproteins, LDL | 1 | 2006 | 640 | 0.060 |
Why?
|
| Eating | 2 | 2008 | 1536 | 0.060 |
Why?
|
| Infant | 3 | 2023 | 35134 | 0.050 |
Why?
|
| Rats | 1 | 2019 | 24252 | 0.050 |
Why?
|
| Antibody Formation | 2 | 2004 | 1402 | 0.050 |
Why?
|
| Minority Groups | 1 | 2010 | 1221 | 0.050 |
Why?
|
| Prospective Studies | 5 | 2011 | 53290 | 0.050 |
Why?
|
| Endpoint Determination | 1 | 2005 | 601 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2004 | 595 | 0.050 |
Why?
|
| Sex Characteristics | 2 | 2010 | 2585 | 0.050 |
Why?
|
| Nurses | 2 | 2009 | 2462 | 0.050 |
Why?
|
| Mice | 5 | 2020 | 81201 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 1 | 2003 | 1681 | 0.050 |
Why?
|
| Military Personnel | 1 | 2010 | 1133 | 0.050 |
Why?
|
| Prevotella | 1 | 2021 | 79 | 0.050 |
Why?
|
| Myocardial Infarction | 4 | 2011 | 11718 | 0.050 |
Why?
|
| Information Systems | 1 | 2003 | 410 | 0.050 |
Why?
|
| Ovary | 1 | 2005 | 981 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2004 | 1590 | 0.050 |
Why?
|
| Mental Recall | 2 | 2005 | 1206 | 0.050 |
Why?
|
| Health Behavior | 2 | 2009 | 2635 | 0.050 |
Why?
|
| Quality Control | 1 | 2003 | 841 | 0.050 |
Why?
|
| Central Nervous System Depressants | 1 | 2021 | 167 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 13991 | 0.050 |
Why?
|
| Coronary Angiography | 2 | 2010 | 4576 | 0.040 |
Why?
|
| United States | 6 | 2021 | 69872 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2023 | 77460 | 0.040 |
Why?
|
| Epidemiologic Methods | 1 | 2005 | 1364 | 0.040 |
Why?
|
| Exercise Test | 1 | 2007 | 2073 | 0.040 |
Why?
|
| Emigration and Immigration | 1 | 2003 | 402 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2021 | 23336 | 0.040 |
Why?
|
| Attitude to Health | 1 | 2009 | 2052 | 0.040 |
Why?
|
| Deficiency Diseases | 1 | 2000 | 72 | 0.040 |
Why?
|
| Breast Diseases | 1 | 2003 | 443 | 0.040 |
Why?
|
| Whole Body Imaging | 1 | 2021 | 280 | 0.040 |
Why?
|
| Logistic Models | 2 | 2011 | 13409 | 0.040 |
Why?
|
| Comorbidity | 2 | 2011 | 10388 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 1701 | 0.040 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2013 | 2200 | 0.040 |
Why?
|
| Glycogen | 1 | 2019 | 259 | 0.040 |
Why?
|
| Disease Progression | 2 | 2018 | 13286 | 0.040 |
Why?
|
| Case-Control Studies | 4 | 2017 | 21748 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2005 | 19905 | 0.040 |
Why?
|
| Waist-Hip Ratio | 1 | 2019 | 517 | 0.040 |
Why?
|
| RNA, Messenger | 4 | 2017 | 13035 | 0.040 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2000 | 303 | 0.040 |
Why?
|
| Family Practice | 1 | 2000 | 516 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2002 | 1842 | 0.040 |
Why?
|
| Fertilization in Vitro | 1 | 2005 | 1284 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2005 | 2266 | 0.040 |
Why?
|
| Metabolome | 1 | 2024 | 895 | 0.040 |
Why?
|
| E2F1 Transcription Factor | 1 | 2017 | 190 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2010 | 5984 | 0.040 |
Why?
|
| Vitamin D | 1 | 2010 | 3224 | 0.040 |
Why?
|
| Hyperglycemia | 1 | 2005 | 1373 | 0.030 |
Why?
|
| Amino Acids, Aromatic | 1 | 2016 | 32 | 0.030 |
Why?
|
| Louisiana | 1 | 2016 | 108 | 0.030 |
Why?
|
| Social Class | 1 | 2005 | 1997 | 0.030 |
Why?
|
| Stomach | 1 | 2020 | 697 | 0.030 |
Why?
|
| Registries | 1 | 2011 | 8091 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2010 | 6542 | 0.030 |
Why?
|
| Educational Status | 3 | 2011 | 2540 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2016 | 537 | 0.030 |
Why?
|
| Anthropometry | 2 | 2013 | 1350 | 0.030 |
Why?
|
| Fabaceae | 1 | 2014 | 103 | 0.030 |
Why?
|
| Sample Size | 1 | 2018 | 845 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2007 | 6442 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 21833 | 0.030 |
Why?
|
| Calcinosis | 1 | 2003 | 1499 | 0.030 |
Why?
|
| Language | 1 | 2003 | 1471 | 0.030 |
Why?
|
| Nutrition Assessment | 2 | 2010 | 723 | 0.030 |
Why?
|
| Breast | 1 | 2003 | 1970 | 0.030 |
Why?
|
| Lumbar Vertebrae | 1 | 2023 | 1848 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2006 | 2789 | 0.030 |
Why?
|
| Physical Fitness | 1 | 1998 | 732 | 0.030 |
Why?
|
| Trace Elements | 1 | 2014 | 198 | 0.030 |
Why?
|
| Africa | 1 | 2014 | 672 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 2887 | 0.030 |
Why?
|
| Neoplasms | 1 | 2021 | 21696 | 0.030 |
Why?
|
| Lanosterol | 1 | 2011 | 3 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2016 | 1341 | 0.030 |
Why?
|
| Fishes | 1 | 2014 | 569 | 0.030 |
Why?
|
| Phytosterols | 1 | 2011 | 64 | 0.020 |
Why?
|
| Cause of Death | 1 | 2021 | 3582 | 0.020 |
Why?
|
| Physicians | 1 | 2009 | 4567 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2000 | 2278 | 0.020 |
Why?
|
| Cell Movement | 2 | 2016 | 5218 | 0.020 |
Why?
|
| Glucose | 1 | 2022 | 4398 | 0.020 |
Why?
|
| Tissue Banks | 1 | 2010 | 184 | 0.020 |
Why?
|
| Mortality | 1 | 2021 | 2864 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2020 | 2974 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2017 | 19233 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2022 | 5023 | 0.020 |
Why?
|
| Pregnancy | 1 | 2010 | 29144 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2016 | 3001 | 0.020 |
Why?
|
| Nutritional Status | 2 | 2009 | 1609 | 0.020 |
Why?
|
| Age Distribution | 2 | 2005 | 2902 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2017 | 4208 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2013 | 1355 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2004 | 7282 | 0.020 |
Why?
|
| Morbidity | 1 | 2013 | 1768 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2013 | 1539 | 0.020 |
Why?
|
| Public Health | 1 | 2020 | 2602 | 0.020 |
Why?
|
| China | 1 | 2013 | 2245 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2013 | 1725 | 0.020 |
Why?
|
| Biopsy | 2 | 2010 | 6755 | 0.020 |
Why?
|
| Cluster Analysis | 2 | 2005 | 2715 | 0.020 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2010 | 378 | 0.020 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2007 | 193 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 625 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 2505 | 0.020 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2018 | 1519 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2009 | 607 | 0.020 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2010 | 582 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2016 | 5974 | 0.020 |
Why?
|
| Cardiovascular System | 1 | 2013 | 831 | 0.020 |
Why?
|
| Appetite Depressants | 1 | 2005 | 110 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2007 | 619 | 0.020 |
Why?
|
| Socioeconomic Factors | 2 | 2010 | 7785 | 0.010 |
Why?
|
| Minerals | 1 | 2005 | 275 | 0.010 |
Why?
|
| Docosahexaenoic Acids | 1 | 2010 | 875 | 0.010 |
Why?
|
| Blood Specimen Collection | 1 | 2004 | 246 | 0.010 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2005 | 402 | 0.010 |
Why?
|
| Prediabetic State | 1 | 2008 | 499 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2009 | 3702 | 0.010 |
Why?
|
| Boston | 1 | 2016 | 9312 | 0.010 |
Why?
|
| Lymphocyte Activation | 2 | 2004 | 5524 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2010 | 5181 | 0.010 |
Why?
|
| Gene Expression | 1 | 2016 | 7798 | 0.010 |
Why?
|
| Antibodies, Viral | 2 | 2004 | 3177 | 0.010 |
Why?
|
| Transients and Migrants | 1 | 2005 | 155 | 0.010 |
Why?
|
| Immunization Schedule | 1 | 2003 | 221 | 0.010 |
Why?
|
| Immunoglobulin G | 2 | 2004 | 4561 | 0.010 |
Why?
|
| Translating | 1 | 2003 | 144 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2009 | 1403 | 0.010 |
Why?
|
| Immunization, Secondary | 1 | 2003 | 340 | 0.010 |
Why?
|
| Urban Population | 1 | 2009 | 2022 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2004 | 1588 | 0.010 |
Why?
|
| Lipoproteins | 1 | 2004 | 878 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2005 | 2297 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 3873 | 0.010 |
Why?
|
| Rural Population | 1 | 2009 | 2207 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 15520 | 0.010 |
Why?
|
| Reference Values | 1 | 2005 | 4982 | 0.010 |
Why?
|
| Antibodies | 1 | 2006 | 2460 | 0.010 |
Why?
|
| Geriatric Assessment | 1 | 2005 | 1372 | 0.010 |
Why?
|
| Pharmaceutical Preparations | 1 | 2005 | 1070 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2010 | 8319 | 0.010 |
Why?
|
| Prevalence | 2 | 2005 | 15221 | 0.010 |
Why?
|
| Vitamins | 1 | 2005 | 1623 | 0.010 |
Why?
|
| Patient Selection | 1 | 2008 | 4216 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2016 | 12207 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2003 | 2539 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2006 | 3084 | 0.010 |
Why?
|
| Models, Biological | 1 | 2011 | 9584 | 0.010 |
Why?
|
| Age Factors | 2 | 2003 | 18373 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 2003 | 1170 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2003 | 2133 | 0.010 |
Why?
|
| Mutation | 1 | 2018 | 29786 | 0.010 |
Why?
|
| Mammography | 1 | 2003 | 2475 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14723 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2005 | 12356 | 0.010 |
Why?
|
| Mass Screening | 1 | 2003 | 5253 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2009 | 23404 | 0.000 |
Why?
|
| Prognosis | 1 | 2005 | 29060 | 0.000 |
Why?
|
| Child | 2 | 2003 | 77709 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 2000 | 15535 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2005 | 57776 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2000 | 25628 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2000 | 41005 | 0.000 |
Why?
|